Breaking News, Collaborations & Alliances

Thousand Oaks Biologics, GeneQuantum Partner for ADC Drug Development

GQ will leverage TOBio's expertise in CMC and commercial manufacturing.

Thousand Oaks Biologics Inc. and GeneQuantum Healthcare Co., Ltd. (GQ) entered into a strategic partnership focusing on the CMC development of ADC products with a core conjugation technology for more stable drug candidates. The over 200 million RMB collaboration will allow GQ to leverage TOBio’s expertise in CMC and commercial manufacturing to advance its pharmaceutical research on ADC products and enable GQ to speed up its Biologics License Applications. Meanwhile, GQ will share with T...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters